Association of systemic inflammatory biomarkers with morphological characteristics of coronary atherosclerotic plaque by intravascular optical coherence tomography

2011 Libby, 2012, Inflammation in atherosclerosis, Arterioscler Thromb Vasc Biol, 32, 2045, 10.1161/ATVBAHA.108.179705 Libby, 2009, Inflammation in atherosclerosis: from pathophysiology to practice, J Am Coll Cardiol, 54, 2129, 10.1016/j.jacc.2009.09.009 Sukhova, 1999, Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques, Circulation, 99, 2503, 10.1161/01.CIR.99.19.2503 Tousoulis, 2018, Novel biomarkers in heart failure. What they add in daily clinical practice?, Hellenic J Cardiol HJC : HJC = Hellenike kardiologike epitheorese, 59, 193, 10.1016/j.hjc.2018.08.007 Lovic, 2018, Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation, Hellenic J Cardiol HJC : HJC = Hellenike kardiologike epitheorese, 59, 226, 10.1016/j.hjc.2018.02.002 Toutouzas, 2015, Vulnerable plaque imaging: updates on new pathobiological mechanisms, Eur Heart J, 36, 3147, 10.1093/eurheartj/ehv508 Burke, 1997, Coronary risk factors and plaque morphology in men with coronary disease who died suddenly, N Engl J Med, 336, 1276, 10.1056/NEJM199705013361802 Virmani, 2000, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 20, 1262, 10.1161/01.ATV.20.5.1262 Toutouzas, 2011, New insights by optical coherence tomography into the differences and similarities of culprit ruptured plaque morphology in non-ST-elevation myocardial infarction and ST-elevation myocardial infarction, Am Heart J, 161, 1192, 10.1016/j.ahj.2011.03.005 Yabushita, 2002, Characterization of human atherosclerosis by optical coherence tomography, Circulation, 106, 1640, 10.1161/01.CIR.0000029927.92825.F6 van der Sijde, 2016, Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound, Eur Heart J Cardiovasc Imag, 10.1093/ehjci/jew037 Karanasos, 2012, Optical Coherence Tomography: Potential Clinical Applications, Curr Cardiovasc Imag Rep, 5, 206, 10.1007/s12410-012-9140-x Jang, 2005, In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography, Circulation, 111, 1551, 10.1161/01.CIR.0000159354.43778.69 Jang, 2002, Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound, J Am Coll Cardiol, 39, 604, 10.1016/S0735-1097(01)01799-5 Kolodgie, 2001, The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes, Curr Opin Cardiol, 16, 285, 10.1097/00001573-200109000-00006 Raffel, 2007, Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography, Arterioscler Thromb Vasc Biol, 27, 1820, 10.1161/ATVBAHA.107.145987 Bouki, 2012, Inflammatory markers and plaque morphology: an optical coherence tomography study, Int J Cardiol, 154, 287, 10.1016/j.ijcard.2010.09.059 Niccoli, 2014, Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications, Int J Cardiol, 171, 463, 10.1016/j.ijcard.2013.12.238 Kashiwagi, 2009, Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome, Circ J, 73, 1291, 10.1253/circj.CJ-08-0968 Fujii, 2008, Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study, J Am Coll Cardiol, 52, 787, 10.1016/j.jacc.2008.05.030 Koga, 2013, Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound, JACC Cardiovasc Interv, 6, 945, 10.1016/j.jcin.2013.04.024 Liu, 2013, Relationship between serum neopterin levels and coronary heart disease, Genet Mol Res, 12, 4222, 10.4238/2013.October.7.8 Kaski, 2008, Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome, Atherosclerosis, 201, 176, 10.1016/j.atherosclerosis.2008.01.009 Sun, 2015, Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study, Atherosclerosis, 241, 138, 10.1016/j.atherosclerosis.2015.04.818 Baldus, 2003, Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes, Circulation, 108, 1440, 10.1161/01.CIR.0000090690.67322.51 Brennan, 2003, Prognostic value of myeloperoxidase in patients with chest pain, N Engl J Med, 349, 1595, 10.1056/NEJMoa035003 Kolodgie, 2002, Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion, Arterioscler Thromb Vasc Biol, 22, 1642, 10.1161/01.ATV.0000034021.92658.4C Burke, 1998, Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women, Circulation, 97, 2110, 10.1161/01.CIR.97.21.2110 Malmberg, 1995, Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year, J Am Coll Cardiol, 26, 57, 10.1016/0735-1097(95)00126-K Teraguchi, 2014, Impact of glucose fluctuation and monocyte subsets on coronary plaque rupture, Nutr Metabol Cardiovasc Dis, 24, 309, 10.1016/j.numecd.2013.08.010 Gu, 1998, Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice, Mol Cell, 2, 275, 10.1016/S1097-2765(00)80139-2 Rinder, 1991, Activated and unactivated platelet adhesion to monocytes and neutrophils, Blood, 78, 1760, 10.1182/blood.V78.7.1760.1760 Ozaki, 2014, Association between P-selectin glycoprotein ligand-1 and pathogenesis in acute coronary syndrome assessed by optical coherence tomography, Atherosclerosis, 233, 697, 10.1016/j.atherosclerosis.2013.12.052 Holvoet, 1998, Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease, Circulation, 98, 1487, 10.1161/01.CIR.98.15.1487 Matsuo, 2013, Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease, European Heart J Cardiovasc Imag, 14, 43, 10.1093/ehjci/jes094 Kato, 2009, Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice, Arterioscler Thromb Vasc Biol, 29, 33, 10.1161/ATVBAHA.108.164723 Kromhout, 1985, The inverse relation between fish consumption and 20-year mortality from coronary heart disease, N Engl J Med, 312, 1205, 10.1056/NEJM198505093121901 Booyens, 1985, Chronic arachidonic acid eicosanoid imbalance: a common feature in coronary artery disease, hypercholesterolemia, cancer and other important diseases. Significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway, Med Hypotheses, 18, 53, 10.1016/0306-9877(85)90120-3 Hasegawa, 2014, Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study, Heart Ves, 29, 596, 10.1007/s00380-013-0404-4 Wakabayashi, 2015, Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography, J Cardiol Omland, 2009, A sensitive cardiac troponin T assay in stable coronary artery disease, N Engl J Med, 361, 2538, 10.1056/NEJMoa0805299 Lee, 2015, Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention, Circ Cardiovasc Intervent, 8, 10.1161/CIRCINTERVENTIONS.114.001727 Hsieh, 2000, Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL, Atherosclerosis, 151, 481, 10.1016/S0021-9150(00)00453-6 Mallat, 2010, Lipoprotein-associated and secreted phospholipases A(2) in cardiovascular disease: roles as biological effectors and biomarkers, Circulation, 122, 2183, 10.1161/CIRCULATIONAHA.110.936393 Gu, 2014, Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?, Coron Artery Dis, 25, 10, 10.1097/MCA.0000000000000041 Ferrante, 2010, High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study, Circulation, 122, 2505, 10.1161/CIRCULATIONAHA.110.955302